Bioleaders Corporation (142760) — Financial Flexibility Index
Bioleaders Corporation (142760) has a Financial Flexibility Index of -0.09x as of December 2025. Free cash flow of ₩-1.11 Billion (operating CF ₩-1.26 Billion minus capex ₩149.80 Million) represents 0% of total liabilities (₩12.04 Billion). Also explore 142760 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioleaders Corporation Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Bioleaders Corporation across 11 annual periods. Check 142760 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bioleaders Corporation (2015–2025)
Year-by-year free cash flow to debt coverage for Bioleaders Corporation. For the full company profile including market capitalisation, see Bioleaders Corporation stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | ₩-5.76 Billion | ₩-5.97 Billion | ₩12.04 Billion | ▼ -2260.6% |
| 2024 | 0.02x | ₩551.95 Million | ₩-501.75 Million | ₩24.94 Billion | ▼ -95.5% |
| 2023 | 0.49x | ₩6.55 Billion | ₩6.18 Billion | ₩13.28 Billion | ▲ +431.2% |
| 2022 | -0.15x | ₩-18.89 Billion | ₩-20.60 Billion | ₩126.73 Billion | ▼ -555.3% |
| 2021 | -0.02x | ₩-3.27 Billion | ₩-5.04 Billion | ₩143.74 Billion | ▼ -129.5% |
| 2020 | 0.08x | ₩12.36 Billion | ₩-5.43 Billion | ₩160.09 Billion | ▼ -55.0% |
| 2019 | 0.17x | ₩21.31 Billion | ₩-2.20 Billion | ₩124.30 Billion | ▲ +572.5% |
| 2018 | -0.04x | ₩-4.71 Billion | ₩-8.77 Billion | ₩129.79 Billion | ▲ +98.5% |
| 2017 | -2.46x | ₩-5.94 Billion | ₩-8.53 Billion | ₩2.41 Billion | ▼ -63.3% |
| 2016 | -1.51x | ₩-6.26 Billion | ₩-7.70 Billion | ₩4.15 Billion | ▼ -35.0% |
| 2015 | -1.12x | ₩-4.45 Billion | ₩-4.83 Billion | ₩3.99 Billion | — |